A New Treatment for the Reconstruction of the Medial Compartment of the Ankle: The Combined Use of Biological Materials

Abstract

Fractures, especially if articular and periarticular, are frequently associated to functional and clinical disabling outcomes and chronic pain. In particular, the injuries with loss of bone, ligament, and/or tendon tissue in which the full recovery of the wound area is not obtained are the worst anatomical/pathological conditions to heal. In this study, three different biological materials were used as regenerative approaches to rebuild the medial malleolus fracture of the ankle in which loss of bone, ligament, and tendon tissue occur. In particular, the morselized human bone tissue was combined with the human dermis decellularized, both augmented with homologous platelet-rich plasma. The magnetic resonance imaging study with contrast at the follow-up showed a signal compatible with vascularization of the tissue without sign of degeneration. Our new regenerative approach in which different biological materials were combined together showed a good choice of treatment for the reconstruction of not repairable outcome of a fracture.

Keywords

ankle - reconstruction - biomaterials - fractures

Publikationsverlauf

Eingereicht: 08. Mai 2019

Angenommen: 18. April 2021

Artikel online veröffentlicht:
18. Juni 2021

• References

• 1 García-Gareta E, Coathup MJ, Blunn GW. Osteoinduction of bone grafting materials for bone repair and regeneration. Bone 2015; 81: 112-121
• 2 Albrektsson T, Johansson C. Osteoinduction, osteoconduction and osseointegration. Eur Spine J 2001; 10 (Suppl. 02) S96-S101
• 3 Fernandez de Grado G, Keller L, Idoux-Gillet Y. et al. Bone substitutes: a review of their characteristics, clinical use, and perspectives for large bone defects management. J Tissue Eng 2018; 9: 2041731418776819
• 4 Wang W, Yeung KWK. Bone grafts and biomaterials substitutes for bone defect repair: a review. Bioact Mater 2017; 2 (04) 224-247
• 5 Bondioli E, Fini M, Veronesi F. et al. Development and evaluation of a decellularized membrane from human dermis. J Tissue Eng Regen Med 2014; 8 (04) 325-336
• 6 Fosnot J, Kovach III SJ, Serletti JM. Acellular dermal matrix: general principles for the plastic surgeon. Aesthet Surg J 2011; 31 (7, Suppl): 5S-12S
• 7 Han L, Fang WL, Jin B, Xu SC, Zheng X, Hu YG. Enhancement of tendon-bone healing after rotator cuff injuries using combined therapy with mesenchymal stem cells and platelet rich plasma. Eur Rev Med Pharmacol Sci 2019; 23 (20) 9075-9084
• 8 Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 2009; 37 (11) 2259-2272
• 9 Mariani E, Pulsatelli L. Platelet concentrates in musculoskeletal medicine. Int J Mol Sci 2020; 21 (04) E1328
• 10 Jones CP, Loveland J, Atkinson BL, Ryaby JT, Linovitz RJ, Nunley JA. Prospective, multicenter evaluation of allogenic bone matrix containing viable osteogenic cells in foot and/or ankle arthrodesis. Foot Ankle Int 2015; 36 (10) 1129-1137
• 11 Hohn EA, Gillette BP, Burns JP. Outcomes of arthroscopic revision rotator cuff repair with acellular human dermal matrix allograft augmentation. J Shoulder Elbow Surg 2018; 27 (05) 816-823
• 12 Acevedo DC, Shore B, Mirzayan R. Orthopedic applications of acellular human dermal allograft for shoulder and elbow surgery. Orthop Clin North Am 2015; 46 (03) 377-388
• 13 Aspenberg P, Virchenko O. Platelet concentrate injection improves Achilles tendon repair in rats. Acta Orthop Scand 2004; 75 (01) 93-99
• 14 Smrke D, Gubina B, Domanoviç D, Rozman P. Allogeneic platelet gel with autologous cancellous bone graft for the treatment of a large bone defect. Eur Surg Res 2007; 39 (03) 170-174
• 15 Bibbo C, Hatfield PS. Platelet-rich plasma concentrate to augment bone fusion. Foot Ankle Clin 2010; 15 (04) 641-649
• 16 Wei LC, Lei GH, Sheng PY. et al. Efficacy of platelet-rich plasma combined with allograft bone in the management of displaced intra-articular calcaneal fractures: a prospective cohort study. J Orthop Res 2012; 30 (10) 1570-1576
• 17 Bottegoni C, Dei Giudici L, Salvemini S, Chiurazzi E, Bencivenga R, Gigante A. Homologous platelet-rich plasma for the treatment of knee osteoarthritis in selected elderly patients: an open-label, uncontrolled, pilot study. Ther Adv Musculoskelet Dis 2016; 8 (02) 35-41
• 18 Jeong WH, Roh TS, Kim YS. et al. Acceleration of osteogenesis by platelet-rich plasma with acellular dermal matrix in a calvarial defect model. Childs Nerv Syst 2016; 32 (09) 1653-1659
• 19 Çetiner D, Gökalp Kalabay P, Özdemir B, Çankaya ZT. Efficiency of platelet-rich plasma on acellular dermal matrix application with coronally advanced flap in the treatment of multiple adjacent gingival recessions: a randomized controlled clinical trial. J Dent Sci 2018; 13 (03) 198-206
• 20 Melandri D, Marongiu F, Carboni A. et al. A new human-derived acellular dermal matrix for 1-stage coverage of exposed tendons in the foot. Int J Low Extrem Wounds 2020; 19 (01) 78-85
• 21 Bondioli E, Purpura V, Orlandi C. et al. The use of an acellular matrix derived from human dermis for the treatment of full-thickness skin wounds. Cell Tissue Bank 2019; 20 (02) 183-192
• 22 Folli S, Curcio A, Melandri D. et al. A new human-derived acellular dermal matrix for breast reconstruction available for the European market: preliminary results. Aesthetic Plast Surg 2018; 42 (02) 434-441
• 23 Ghetti M, Bondioli E, Purpura V, Cenacchi G, Ruscelli P, Melandri D. Decellularized human dermal matrix produced by a skin bank: a new treatment for abdominal wall defects. Ann Ital Chir 2017; 5: 443-448
• 24 Rotini R, Marinelli A, Guerra E. et al. Human dermal matrix scaffold augmentation for large and massive rotator cuff repairs: preliminary clinical and MRI results at 1-year follow-up. Musculoskelet Surg 2011; 95 (Suppl. 01) S13-S23